Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo

International Journal of Dermatology

Volumn 44, Issue 9, 2005, Pages 736-742

  Hartmann, Anke ^a   Lurz, Christa ^a   Hamm, Henning ^a   Bröcker, Eva B ^a   Hofmann, Uta B ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CAROTENE; METHOXSALEN; PLACEBO; CALCITRIOL; DERMATOLOGICAL AGENT; DRUG DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MEDICAL DOCUMENTATION; MEDICAL PHOTOGRAPHY; MONOTHERAPY; OINTMENT; PHOTOTHERAPY; QUALITY OF LIFE; SCORING SYSTEM; SKIN DEFECT; SKIN PIGMENTATION; STATISTICAL SIGNIFICANCE; ULTRAVIOLET B RADIATION; VITILIGO; COMPARATIVE STUDY; ERYTHEMA; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PRURITUS; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; CALCITRIOL; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; ERYTHEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PRURITUS; QUALITY OF LIFE; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 24944477442     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02154.x     Document Type: Article

References (31)

1. King RA, Oetting WS. Disorders of melanocytes. In: Fitzpatrick TB, Freedberg IM, Eisen AZ, et al., eds. Dermatology in General Medicine. New York: McGraw-Hill, 1999: 925-936.
2. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38: 642-666.
3. Kwok YKC, Anstey AV, Hawk JLM. Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study. Clin Dermatol 2002; 27: 104-110.
4. Orecchia G, Perfetti L. Photochemotherapy with topical khellin and sunlight in vitiligo. Dermatology 1992; 184: 120-123.
5. Köster W, Wiskemann A. Phototherapy with UV-B in vitiligo. Z Hautkr 1990; 65: 1022-1029.
6. Thiele B. Repigmentation treatment of vitiligo with 1-phenylalanine and UVA irradiation. Akt Dermatol 1991; 17: 53-57.
7. Rosenbach TH, Wellenreuther U, Nürnberger F, et al. Treatment of vitiligo with phenylalanine and UV-A. Hautarzt 1993; 44: 208-209.
8. Njoo MD, Spuls PI, Bos JD, et al. Nonsurgical repigmentation therapies in vitiligo - metaanalysis of the literature. Arch Dermatol 1998; 134: 1532-1540.
9. Kokelj F, Lavaroni G, Perkan V, et al. Hyperpigmentation due to calcipotriol plus heliotherapy in psoriatic patients. Acta Derm Venereol 1995; 75: 307-309.
10. 3 possibly mediates skin pigmentation after sun exposure. J Invest Dermatol 1988; 90: 882-884.
11. 3 receptors in normal and psoriatic skin. J Invest Dermatol 1991; 97: 130-139.
12. Schallreuter-Wood KU, Pittelkow MR, Swanson NN. Defective calcium transport in vitiliginous melanocytes. Arch Dermatol Res 1996; 288: 11-13.
13. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998; 197: 167-170.
14. Yalçin B, Sahin S, Bükülmez G, et al. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study. J Am Acad Dermatol 2001; 44: 634-637.
15. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UVB radiation vs topical psoralen plus UVA. Arch Dermatol 1997; 133: 1525-1528.
16. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
17. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
18. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997; 136: 305-314.
19. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
20. Menchini G, Tsoureli-Nikita E, Hercogova J. Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo. J Eur Acad Dermatol Venereol 2003; 17: 171-177.
21. Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol 2002; 46: 727-731.
22. Flindt-Hansen H, McFadden N, Eeg-Larsen T, et al. Effect of narrow-band UVB lamp on photocarcinogenesis in mice. Acta Derm Venereol 1991; 71: 245-248.
23. Young AR. Carcinogenicity of UVB phototherapy assessed. Lancet 1995; 345: 1431-1432.
24. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy follow-up study. Cancer 1994; 73: 2759-2764.
25. Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol 1999; 16: 317-320.
26. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 2001; 145: 476-479.
27. Ermis O, Alpsoy E, Cetin L, et al. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol 2001; 145: 472-475.
28. Chiavérini C, Passeron T, Ortonne JP. Treatment of vitiligo by topical calcipotriol. J Eur Acad Derm Venereol 2002; 16: 137-138.
29. 3-induced metallothionein in photoprotection against UVB injury in mouse skin and cultured rat keratinocytes. J Dermatol Sci 1995; 9: 203-208.
30. Youn JI, Park BS, Chung JH, et al. Photoprotective effect of calcipotriol upon skin photoreaction to UVA and UVB. Photoderm Photoimmun Photomed 1997; 13: 109-114.
31. Dogra S, Parsad D. Combination of narrowband UV-B and topical calcipotriene in vitiligo. Arch Dermatol 2003; 139: 393.